Echocardiographic analysis showed that the knockdown of SRSF9 significantly alleviated cardiac dysfunction, reduced cardiac dilatation, and LVPW;d induced by TAC (Figure 5C; Table S5, Supporting Information). The gene discussed is SRSF9; the disease is Vascular dilatation.